If you remember within a few hours, take the missed 100 mg tablet right away. If the next scheduled dose is near, skip the missed tablet and continue with the regular schedule. Do not double a dose.
Mebendazole passes into breast milk in small amounts. It is generally discouraged unless the benefit to the mother outweighs potential risk to the infant. Discuss alternatives with your clinician.
A follow-up stool examination is typically performed 7-14 days after completing therapy to confirm eradication of the parasite.
Antacids have no known direct interaction with mebendazole, but taking the medication on an empty stomach maximizes its local effect in the intestine.
Its chemical structure limits passage through the intestinal wall, which is advantageous because the drug’s target-intestinal worms-are located within the gut lumen.
Mebendazole is not the first-line treatment for most tapeworm species; other agents such as praziquantel are preferred. Use only as directed by a healthcare professional.
Standard regimens recommend 100 mg twice daily for three days; a repeat course after two weeks may be advised for complete eradication, depending on the clinician’s assessment.
No specific diet is required, but avoiding a high-fat meal around the time of dosing can help maintain the drug’s low systemic absorption profile.
Mebendazole is not listed on standard performance-enhancing drug panels. However, disclose any medication use to the testing authority if required.
Mebendazole is an antiparasitic medication classified within the anthelmintic drug family. It is most commonly supplied as a 100 mg oral pill. In Hong Kong, mebendazole is a prescription-only (Rx) medication overseen by the Department of Health’s Drug Office. The active ingredient-mebendazole-targets a range of intestinal worms, helping to eliminate infections that can cause abdominal discomfort, nutritional deficiencies, and other health problems.
Mebendazole interferes with the parasite’s ability to absorb glucose, a vital energy source. By binding to the worm’s microtubule protein tubulin, it disrupts microtubule formation, leading to impaired nutrient uptake and eventual death of the parasite. Because human cells lack the same tubulin binding sites, the drug’s action is largely selective for helminths. After oral administration, mebendazole is poorly absorbed (bioavailability ≤5 %), which concentrates the drug in the intestinal lumen where the parasites reside. This limited systemic exposure also reduces the risk of serious systemic side effects.
Key pharmacologic points:
Mebendazole is approved for the treatment of several intestinal helminth infections, including:
These indications are recognized by health authorities worldwide, and Hong Kong’s Drug Office lists them as the primary therapeutic uses. The medication is typically prescribed for adults and children over 2 years of age, though dosing adjustments may be needed for younger patients.
Patients experiencing persistent gastrointestinal upset should notify a healthcare professional.
Mebendazole is short-acting; no tapering is required. Therapy may be stopped once the prescribed course is completed, even if mild side effects persist, as they typically resolve quickly.
This article provides educational information about mebendazole and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
